Search Results

Site Search

Neurofascin 155 IgG4 Antibody Test [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of...

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D. - Insights

Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's...

Autoimmune Myelopathy Testing - Mayo Clinic Laboratories

Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis.

Thrombotic microangiopathy (TMA) - Insights

View our comprehensive testing suite designed to confirm diagnosis and facilitate treatment of thrombotic microangiopathy.

MAG Antibody Testing [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D. - Insights

Maria Willrich, Ph.D., and Melissa Snyder, Ph.D., describe Mayo Clinic Laboratories' panel for proactive therapeutic drug monitoring of patients with inflammatory bowel disease. The panel expands options for clinicians assessing patients'...

Calprotectin and Inflammatory Bowel Disease - Insights

The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot...

New tests launched in December - Insights

In December 2022, Mayo Clinic Laboratories announced seventy-eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

MCL Molecular Genetics Biochemical Disorders Patient Information MC1235100

MCL Molecular Genetics Biochemical Disorders Patient Information Complete print Reset Form Molecular Genetics Biochemical Disorders Patient Information Instructions accurate interpretation reporting genetic results

MCL Chromosomal Microarray Testing Prenatal Information MC1235196

MCL Chromosomal Microarray Testing Prenatal Information Complete print Chromosomal Microarray Prenatal Products Conception Information Reset Form Instructions accurate interpretation reporting